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Hyperkalemia: An adaptive response in chronic renal insuffi- crease rather than a maldistribution in body K stores,
ciency. and that it promotes K excretion by directly stimulating
Background. Hyperkalemia is a common feature of chronic
K secretion in the principal cells of the collecting ductrenal insufficiency, usually ascribed to impaired K homeosta-
of the kidney. Based on such evidence, we postulate thatsis. However, various experimental observations suggest that
the increase in extracellular [K] actually functions in a homeo- hyperkalemia in renal insufficiency is an adaptive change
static fashion, directly stimulating renal K excretion through that serves to restore K balance in the face of a reduc-
an effect that is independent of, and additive to, aldosterone.
tion in functioning nephrons. This “K adaptation” isMethods. We have reviewed relevant studies in experimen-
the key to establishing a new homeostatic set point attal animals and in human subjects that have examined the reg-
ulation of K excretion and its relation to plasma [K]. which K excretion again matches intake. In addition,
Results. Studies indicate that (1) extracellular [K] in pa- it may provide protection against surges in plasma [K]tients with renal insufficiency correlates directly with intracellu-
that might otherwise occur in chronic renal insufficiency.lar K content, and (2) hyperkalemia directly promotes K secre-
tion in the principal cells of the collecting duct by increasing
apical and basolateral membrane conductances. The effect of
hyperkalemia differs from that of aldosterone in that K con- INCIDENCE OF HYPERKALEMIA IN
ductances are increased as the primary event. The changes in RENAL INSUFFICIENCYprincipal cell function and structure induced by hyperkalemia
are indistinguishable from the effects seen in adaptation to a The incidence of hyperkalemia in patients with chronic
high K diet. renal insufficiency is difficult to assess because of the
Conclusions. We propose that hyperkalemia plays a pivotal
almost universal use of drugs that influence plasma [K].role in K homeostasis in renal insufficiency by stimulating K
excretion. In patients with chronic renal insufficiency, a new In one study carried out before angiotensin-converting
steady state develops in which extracellular [K] rises to the level enzyme (ACE) inhibitors were available and which ex-
needed to stimulate K excretion so that it again matches intake. cluded patients receiving diuretics, plasma [K] was sig-When this new steady state is achieved, plasma [K] remains
nificantly elevated (average value, 4.9 mmol/L) even instable unless dietary intake increases, glomerular filtration rate
falls, or drugs are given that disrupt the new balance. patients with only mild-moderate renal dysfunction (se-
rum creatinine 2 to 4 mg/dL) [5]. Hyperkalemia appears
to occur more frequently in patients with tubulointersti-
Hyperkalemia in chronic renal insufficiency is gener- tial disease or diabetes mellitus [6, 7], but is clearly not
ally viewed as a sign of impaired potassium homeostasis, confined to these disorders [6]. In a random sample of
usually ascribed to toxic effects on cell membrane Na, 300 patients with serum creatinine levels of 1.5 to 6.0
K-ATPase pump activity or to hyporeninemic hypoal-
mg/dL taken from our clinic, excluding individuals with
dosteronism [1–4]. In this review, we propose that hyper-
diabetes and those receiving either diuretics or drugskalemia is not due to a failure in homeostasis, but rather
that impair angiotensin II synthesis or effect, we foundis a physiological success story. Evidence is presented
an incidence of hyperkalemia (plasma [K] 5.0 mmol/Lindicating that hyperkalemia is associated with an in-
or higher) of 55%. In the small group of patients in this
sample meeting our criteria for inclusion (N  18, mean
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serum creatinine, 3.1 mg/dL), hyperkalemia was as likelyrenal failure, ROMK.
to occur with glomerular diseases as with tubulointersti-
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TRANSCELLULAR POTASSIUM HOMEOSTASIS
IN RENAL INSUFFICIENCY
Before reviewing the regulation of K excretion in
patients with chronic renal insufficiency, it is important
to address the issue of whether the hyperkalemia seen
in these patients is due to impaired entry of K into cells
or reflects an increase in intracellular K stores. Two gen-
eral approaches—measurement of total body or striated
muscle K stores, and assessment of cell membrane Na,
K-ATPase activity or function—have been used to ad-
dress this issue. Both approaches have limitations and
have provided conflicting results. The key studies are
discussed below.
Fig. 1. Relationship between plasma [K] and urine K excretion in pa-
tients with chronic renal insufficiency. The solid symbols and upper Body potassium stores
regression line are data obtained in patients with low renin and aldoste-
rone levels; the asterisks and lower regression line are data obtained Measurements of total body K content in patients
in patients with normal renin and aldosterone levels. Reprinted with with renal insufficiency show low or normal values, a
permission from the International Society of Nephrology [7].
finding advanced to support the view that K entry into
cells is impaired [14–22]. It should be emphasized, how-
ever, that these measurements give little information
about intracellular K content [14, 22]. Total body storesPOTASSIUM HOMEOSTASIS IN
will be reduced compared to normal individuals, for ex-RENAL INSUFFICIENCY
ample, if there is a loss of muscle mass (the main reservoirRegardless of whether hyperkalemia is present in the
of intracellular K) due to uremia, even though intracel-steady state, patients with renal insufficiency have a di-
lular K in the remaining muscle cells may be normalminished ability to acutely excrete a K load and, there-
or increased [16, 23]. A more direct assessment offore, have more severe and prolonged hyperkalemia when
intracellular K can be obtained by analyzing the Kchallenged [8, 9]. Because hyperkalemia stimulates aldo-
content of striated muscle obtained in biopsy samples.sterone secretion, one might expect aldosterone levels
Such measurements have shown, in most instances, thatto be higher in patients with renal insufficiency than in
the K content in muscle tissue in patients with evenindividuals with normal renal function. However, aldo-
advanced renal insufficiency is either indistinguishablesterone measurements have shown widely varying pat-
from individuals with normal renal function or increasedterns [3, 7, 10–12], and its importance as a factor in main-
[14, 19, 20].taining K balance in renal insufficiency is uncertain. In
patients with renal insufficiency, plasma [K] has been
Correlation between extracellular and intracellular [K]shown to correlate directly with daily urinary K excre-
The key issue of whether extracellular [K] correlatestion regardless of the circulating aldosterone level [7].
directly with intracellular [K] has been addressed inIn this carefully studied group of patients, those with the
a systematic fashion in only one study [19]. In thishighest plasma [K] had the greatest urinary K ex-
study, in which the K content of muscle samples wascretion (Fig. 1). Assuming these patients are in K bal-
assessed in patients with renal insufficiency (serum creat-ance, those with the highest excretion must also have
inine range, 3.6 to 19.5 mg/dL), plasma [K] correlatedhad the highest dietary K intake.
directly with muscle K content (Fig. 2). The authorsIn a related study, K intake was deliberately increased
found an even stronger correlation between plasma andin patients with stable chronic renal insufficiency (mean
intracellular [K] when they estimated the latter fromcreatinine clearance, 30 mL/min) by giving them a K
the ratio of K content to water content. Therefore,supplement of 50 mmol/day [13]. The patients with renal
hyperkalemia is associated both with a higher muscleinsufficiency increased K excretion to the same degree as
K content and a higher intracellular K/H2O ratio.control subjects given the same supplement but, in con-
trast to the control subjects, achieved this goal by increas-
Assessment of ATPase activity and functioning plasma [K] by 0.7 mmol/L, to a mean value of 5.4
In red cells, white cells, and myocytes taken from pa-mmol/L. These observations suggest a causal linkage be-
tients and experimental animals with renal insufficiency,tween the increase in plasma [K] and stimulation of renal
Na,K-ATPase activity is consistently decreased com-K excretion. The respective roles of extracellular [K],
pared to normal controls [1, 2, 4, 24–26]. However, whenaldosterone, and other factors in maintaining K balance
in renal insufficiency are discussed in detail below. Na, K-ATPase function is tested in animals and hu-
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Renal regulation of K homeostasis
Regardless of whether K distribution in the body is
normal or abnormal in patients with chronic renal insuf-
ficiency, excretion of K must eventually match intake
or lethal hyperkalemia will supervene within days. Potas-
sium excretion by the kidney is tightly regulated and is
determined primarily by events beyond the early distal
tubule where either reabsorption or secretion of K can
occur [37–40]. Potassium excretion almost always ex-
ceeds the amount delivered to the early distal tubule
(except under conditions of sustained K depletion),
indicating that the rate of secretion is the key determi-
nant of K excretion. Secretion of K occurs in the
collecting duct and is mediated primarily by apical mem-
brane K (ROMK) channels in the principal cells [39–
41], although it may be augmented by “maxi-K” channels
in the apical membrane of intercalated cells under condi-
tions of high urine flow rates [42].
Fig. 2. Relationship between plasma [K] and muscle K content in When renal function is normal, aldosterone and tubu-
103 patients with renal insufficiency. Muscle K content (KM) is given lar flow rate to the distal nephron appear to be the key
in mmol/kg of fat-free solids (FFS). The closed symbols are samples
factors regulating K excretion [43], and plasma [K]taken from patients not receiving dialysis therapy, and the open symbols
are from patients receiving either peritoneal or hemodialysis therapy. remains within normal levels over a wide range of dietary
Reprinted with permission from the International Society of Nephrol- K intake. However, as discussed below, the specific
ogy [19].
role of aldosterone remains somewhat controversial and
other regulatory influences, perhaps even extracellular
[K] itself, may play a role [44]. In adrenalectomized
dogs on fixed aldosterone replacement, for example, anmans with renal insufficiency, no abnormality is detected.
increase in plasma [K] increases urinary K excretionStimulation of Na,K-ATPase activity by either insulin
without any change in Na excretion [45]. In individualsor K administration, assessed by K entry into cells, is
with renal insufficiency, flow rate to the remaining func-not impaired [6, 8, 9, 26, 27]. In one study, K entry into
tioning tubules is already maximized so that other factorscells in response to insulin was actually greater in uremic
must come into play to regulate K excretion. We willrats than in normal controls [26]. The reason for the
examine the evidence that plasma [K] itself is a keydecrease in Na,K-ATPase activity in ex vivo samples
player, which interacts with aldosterone and other fac-remains unexplained.
tors to regulate K excretion in patients with renal insuf-
ficiency.Effects of aldosterone
The activity of Na,K-ATPase is stimulated by aldo- Principal cell K secretion
sterone, and therefore hypoaldosteronism has been im- Potassium secretion through principal cells of the col-
plicated to cause hyperkalemia by impairing K entry lecting duct is a two-step process involving (1) cellular K
into cells [1, 3, 4]. However, the role of aldosterone in entry across the basolateral membrane via the Na,K-
transcellular K equilibrium remains controversial [28]. ATPase pump, and (2) K exit across the apical mem-
Although many studies in experimental animals and hu- brane via K channels that open to allow secretion into
man subjects appear to demonstrate a major role for an electronegative lumen (Fig. 3). The electronegativity
sustained changes in aldosterone in transcellular K ho- of the lumen is largely due to Na reabsorption through
meostasis [29–32], most have not been controlled for the epithelial Na channel, ENaC (Fig. 4A). Potassium
changes in body K stores or for the effect of catecho- secretion through apical K channels constitutes the rate-
lamines [28, 31, 33]. Blockade of the normal surge in limiting step of K secretion, and occurs through the
aldosterone after acute K administration has no effect ROMK potassium channel in the principal cells [46, 47].
on the transcellular disposition of administered K Effect of hyperkalemia on K secretion. The specific ef-
[34, 35]. An additional problem with positing an impor- fects of peritubular [K] on distal tubular K secretion
tant effect of aldosterone on transcellular K movement and renal K excretion were first elucidated in a series
is that striated muscle cells, the major intracellular reser- of in situ microperfusion studies in rats [48]. In these
experiments, acute hyperkalemia was induced by intra-voir of K, lack mineralocorticoid receptors [36].
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Fig. 3. Major factors that regulate K secre-
tion in principal cells. Sodium is reabsorbed
across the luminal membrane through ENaC
Na channels, with the resultant cellular depo-
larization increasing the electrical driving
force for K secretion through ROMK K
channels. (1) Elevation of peritubular [K]
(circular arrowheads) increases the density of
luminal ENaC and ROMK channels, which
both promote K secretion by increasing the
electrical driving force and K permeability,
respectively. Increases in peritubular [K] also
activate the Na,K-ATPase pump in the
BLM and stimulate aldosterone release. (2)
Aldosterone (diamond arrowheads) increases
the density of ENaC (but not ROMK) chan-
nels and activates the Na,K-ATPase pump,
both of which increase the driving force for
K secretion. The surface area of the BLM
containing the Na,K-ATPase pump under-
goes amplification during prolonged exposure
to either increased peritubular [K] or aldo-
sterone. (3) Kaliuretic factors, including K
itself, have been proposed that somehow di-
rectly increase K secretion. For example,
high luminal [K] may directly increase the
activity of ROMK channels.
venous K administration into adrenalectomized rats tance in both the apical and basolateral membranes, and
(3) an increase in the apical Na conductance. The in-maintained at a fixed aldosterone level. Hyperkalemia
more than doubled K secretion in perfused surface dis- crease in apical K conductance is due to an increase in
the ROMK K conductance, and the increase in apicaltal tubules and acutely increased urinary K excretion.
The increase in K secretion induced by hyperkalemia Na conductance is due to an increase in the ENaC
Na conductance. The latter plays a key role becausewas the same whether aldosterone secretion rate was
fixed at low or high levels, indicating independence of inhibition of ENaC by amiloride attenuates activation
of the Na,K-ATPase pump, which decreases cellularthis effect of hyperkalemia from aldosterone. Moreover,
Na delivery, pH, tubular flow rate, and transepithelial K entry and therefore K secretion. Conversely, these
effects are amplified by treatment with mineralocorti-potential difference were all controlled, indicating a spe-
cific effect of peritubular [K] on K secretion [48]. coids, which stimulates ENaC [54–56]. Careful microper-
fusion studies also have shown that an acute elevationIn a related study, stimulation of distal tubular K se-
cretion by increases in plasma [K] was shown to occur of peritubular [K] directly activates the basolateral
Na,K-ATPase pump [49, 57], which secondarily in-primarily when [K] was increased from 4 to 6 mmol/L,
with no further effect at higher concentrations [49]. There- creases the apical Na conductance [52, 53]. Both of
these changes elevate the driving force for K secretionfore, the effect is prompt, occurs over a range of plasma
[K] not associated with adverse events in humans, and through apical ROMK channels (Fig. 4B). However, the
signaling mechanisms underlying the “crosstalk” be-acts in a homeostatic fashion to increase urinary K ex-
cretion. Based on these studies, one can estimate that tween the luminal and peritubular membranes remain
unknown [58].more than half of the stimulation of K secretion in the
distal tubule is induced by hyperkalemia, with the re- Interaction between K and aldosterone. The interac-
tion between extracellular [K] and K excretion involvesmainder stimulated by aldosterone [48]. In support of
these results in intact rats, several studies in isolated per- the adrenal cortex as well as the kidney (Figs. 3 and
4). An increase in extracellular [K] is well known tofused rabbit collecting ducts have shown that K secre-
tion is stimulated by an increase in peritubular [K] stimulate aldosterone secretion by the adrenal gland, an
effect facilitated by simultaneous stimulation of angio-[50–53].
The nature of this stimulation has been explored using tensin II secretion [34, 59–61]. This effect is apparent
in patients with renal insufficiency as well; aldosteroneelectrophysiological techniques in isolated rabbit collect-
ing tubules by Muto et al (Fig. 4) [53]. In their study, correlates directly with plasma [K] in these patients
[7]. Aldosterone increases the density and activity ofan increase in peritubular [K] initiated the following
sequence of events: (1) immediate activation of the Na,K-ATPase pumps in the basolateral membrane
(BLM) and Na channels in the apical membrane [52,Na,K-ATPase pump, (2) an increase in the K conduc-
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Fig. 4. Electrophysiology of K secretion and K adaptation in cortical collecting duct (CCD) principal cells. The luminal membrane has ENaC
Na channels and ROMK K channels, and the peritubular membrane has K channels and Na,K-ATPase pumps. The thickness of the arrow
though the channels is proportional to the driving force and the size of the channel is proportional to the conductance. Stimulation of the pump
is denoted by increased thickness. (A) At baseline, K entering across the BLM via the Na,K-ATPase pump is subsequently secreted across
the apical membrane into an electronegative lumen while some K recycles back into the blood. (B) An increase in peritubular [K] activates
the pump and leads to an increase in the K conductance in the BLM, resulting in hyperpolarization of VB. When VB becomes more negative
than EBLMK , the direction of K current reverses, and K enters the cell. An elevation of peritubular [K] also increases the density of apical
membrane conductances; more Na current via ENaC increases lumen electronegativity (VT) and therefore the driving force for K secretion
through a higher density of ROMK channels. (C ) The combination of increased peritubular [K] and mineralocorticoids further augments the
changes described in panel B. Note that aldosterone leads to an increase in the driving force for K secretion through ROMK channels, but does
not increase the density of these channels. The Appendix contains a more detailed description of the electrophysiological profile under each
condition. (Adapted from [56]; used with permission from the American Physiological Society).
53, 58, 62, 63], but does not increase the density of apical K sensors, K channels, and kaliuresis. The transient
hyperkalemia induced by K ingestion and absorptionK channels [64]. These effects of aldosterone, coupled
from the gut is almost certainly the proximate signal forwith the increase in the density of apical K channels
the acute increase in K excretion by the kidney [72–75].induced by peritubular hyperkalemia, result in both an
This renal response begins within 30 minutes of receivingincrease in K permeability and driving force, which is
a K load [6, 72, 75], and probably prevents any detect-an extremely favorable setting for K secretion [54, 55,
able change in systemic [K] [73, 74]. Although aldoste-62, 63, 65].
rone secretion also increases within minutes in responseAdditional gain is built into the system because an
to K loading [34, 75], its role in the rapid increase inincrease in extracellular [K] also stimulates aldosterone
K excretion that follows an oral K load remains con-secretion, which enhances the effect of increased peritu-
troversial [47, 74, 75]. Some investigators have postulatedbular [K] on K secretion. Moreover, if stimulation of
the existence of a neuroenteric kaliuretic reflex involvingsecretion is prolonged, the surface area of the basolateral
a splanchnic K sensor that senses dietary K and some-membrane undergoes amplification [66]. Such a chain of
how stimulates renal tubular K secretion [74, 76]. An-events explains why K adaptation can be rapid [67] and
other possibility is that peritubular [K] itself is therobust [68]. In addition to stimulating K secretion in most important kaliuretic factor.
the kidney, aldosterone stimulates K secretion by the
colonic epithelium, promoting stool K loss [69–71]. In-
ADAPTIVE MECHANISMS OF K EXCRETIONdirect evidence suggests that hyperkalemia also stimu-
lates colonic K secretion independent of aldosterone Sustained hyperkalemia does not occur in individuals
with normal renal function despite marked increases in[69, 70].
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potassium intake, because an adaptive change in distal other putative kaliuretic factors). This augmented signal
will lead not only to activation of the Na,K-ATPasetubular K secretion occurs such that intake is matched
by rapid and equivalent increases in K excretion [31, pump and an increase in apical Na channel density, but
also to an increase in apical K channel density [58],49, 77, 78]. This response of the kidney to high dietary
K intake, first demonstrated in rats [79], is termed po- producing an extremely favorable milieu for K secre-
tion. Because of the decrease in functioning nephronstassium adaptation. The distal tubular events induced by
a high K diet are identical to those observed when ex- in renal insufficiency, the development of sustained
hyperkalemia may actually be required for full K adap-tracellular [K] is increased, suggesting that such an in-
crease may be the signal for K adaptation. In experi- tation in many of these patients.
mental animals, a high K diet induces an increase in
ROMK channels, ENaC channels, and Na,K-ATPase
HYPERKALEMIA: SIGNAL AND EFFECTS
pump activity, in the absence of an increase in aldoste-
Based on the evidence presented in this review, werone secretion. By contrast, when rats are given exoge-
propose the following scheme. Either a reduction in GFRnous aldosterone or maintained on a low Na diet to
or an increase in dietary K intake causes a transientincrease endogenous aldosterone levels, the density of
disequilibrium resulting in an increase in body K stores,apical ENaC channels increases, but there is no change
reflected by an increase in plasma [K] when aldosteronein the number of ROMK channels [47]. Although sus-
or other kaliuretic factors fail to correct the imbalance.tained hyperkalemia does not occur when renal function
In the absence of a rapid ability to increase renal Kis normal in experimental animals or humans ingesting
excretion and correct this disequilibrium, extracellulara high K diet, transient hyperkalemia has been observed
[K] rises until it reaches a level sufficient to produce ain the postprandial period. In human subjects with nor-
sustained augmentation of renal K excretion, so thatmal renal function ingesting a liquid formula diet con-
excretion again matches intake. In this new steady state,taining large amounts of K (5 mmol/kg body weight)
plasma [K] will remain stable at an elevated level untilfor a five-day period, serum K rose transiently to be-
either dietary K intake, aldosterone secretion, or renaltween 5 and 6 mmol/L after meals (R. Tannen, personal
function changes. In patients with low aldosterone levels,communication). Although the factors signaling the ini-
dietary K and renal function become the primary deter-tiation of renal K adaptation remain to be defined, one
minants of plasma [K]. If dietary intake falls or renalfactor could be a repetitive postprandial increase in
function improves, plasma [K] will fall. If intake in-extracellular [K].
creases or renal function deteriorates, plasma [K] willWhatever the underlying mechanisms, K adaptation
rise until balance is again achieved.is characterized by changes in apical K and Na conduc-
tances and in basolateral Na,K-ATPase pump activity
Fragility of the new steady statethat can occur in the absence of aldosterone. In addition
Although a new steady state may be achieved in whichto an increase in plasma [K], urinary [K] may be part
plasma [K] is elevated but stable in patients with renalof the signaling mechanism, as a recent study has demon-
insufficiency, this delicate balance can easily be disrupted.strated that an elevation of luminal [K] also increases
It is apparent from Figure 1 that simply increasing diet-the density of ROMK channels [80], an effect that may
ary K intake can raise extracellular [K] to potentiallycontribute to K adaptation.
dangerous levels. Potassium balance is more commonly
K adaptation in renal insufficiency disrupted by physician intervention. Indeed, the most
common cause of severe hyperkalemia in patients withHow might hyperkalemia induce K adaptation in the
renal insufficiency is physician-prescribed K supple-setting of an overall reduction in functioning nephron
ments [86, 87]. In addition to K itself, drugs that impairmass, when each remaining nephron faces an increased
K homeostasis are often responsible for disrupting theworkload? As discussed earlier, the effects of hyperkale-
new steady state in these patients [88]. Aside from drugmia on the collecting duct are virtually identical to those
effects, a wide range of factors may influence transcellu-seen during K adaptation. They include (1) an amplifi-
lar K distribution and exacerbate hyperkalemia in pa-cation of basolateral membrane area [81] and Na,K-
tients with decreased renal function, including metabolicATPase pump activity [82, 83], (2) an increase in apical
acidosis, reduced-adrenergic activity, and perhaps toxicNa delivery and reabsorption [84], and (3) an increase
effects on cell membrane Na,K-ATPase [4].in K excretion per nephron in order to match K intake
[85]. Based on these observations, the following cascade
Therapeutic implicationsof events may occur in renal insufficiency (Fig. 3). As
Recognition that mild to moderate hyperkalemia isingested K is absorbed and retained due an initial im-
an adaptive response should lead to tolerance of a steady-pairment in K excretion, hyperkalemia develops, ampli-
fying the normal signal to excrete K (aldosterone and state serum [K] of 5.0 to 5.5 mmol/L in patients with
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chronic renal insufficiency. In patients with higher serum with normal renal function on a high potassium diet and
[K] levels, intervention should be directed at uncov- make frequent postprandial measurements of plasma
ering factors such as inadvertent potassium intake (for [K] to see whether transient hyperkalemia occurs. If
example, “salt substitutes”) or drugs that impair K ex- so, one could then examine the relationship between
cretion or transcellular distribution. Given the relation- dietary K and the increase in renal K excretion.
ship shown in Figure 1, important intervention in all
Reprint requests to F. John Gennari, M.D., 2308 Rehab, UHC cam-patients with chronic renal insufficiency and hyperka- pus, Fletcher Allen Health Care, Burlington, Vermont 05401, USA.
lemia should be dietary counseling to assure that foods E-mail: fgennari@zoo.uvm.edu
high in K content are not ingested in excessive amounts.
Reduction in dietary K intake to 2 to 3 g/day may
APPENDIXeven be sufficient to allow continuation of angiotensin
Refer to Figure 4. By convention, the luminal barrier voltage VAinhibiting drugs that can prolong renal survival. Chronic
is positive, the basolateral barrier voltage VB is negative, and theKayexalate therapy should be reserved for patients who
peritubular side is ground. Therefore, the transepithelial voltage, VTare unable to regulate their dietary intake, and acute VA  VB, is negative (that is, electronegative lumen). The Nernst po-
tential (in mV) for K across the luminal membrane is:intervention should be reserved for those patients with
extremely high serum [K] levels (6.5 mmol/L). EapicalK  (25.4) ln([K]lumen/[K]cell)
and that across the peritubular membrane is:
SUMMARY AND FUTURE DIRECTIONS EBLMK  (25.4) ln([K]blood/[K]cell)
We propose that hyperkalemia plays a pivotal role in The equations for the K current across each membrane are:
K homeostasis. It stimulates K excretion and restores
Apical K current:balance when K intake outstrips the kidney’s ability to
IApicalK  G
Apical
K * [(VT  VB)  E
Apical
K ]respond in patients with renal insufficiency. Hyperka-
lemia promotes K excretion by directly stimulating K  GApicalK * [VA  E
Apical
K ]
secretion in collecting duct principal cells. The cellular
where GApicalK is the sum of all luminal K conductances.mechanisms by which K secretion is increased by hyper-
• VT hyperpolarizes if VB hyperpolarizes and/or if the lumen be-kalemia remain to be determined, but the effect is inde-
comes more negative (for example, with mineralocorticoid treat-pendent of, and additive to, the effects of aldosterone. ment and activation of ENaC).
In patients with renal insufficiency, extracellular [K] • VT depolarizes if VB depolarizes and/or if the lumen becomes less
negative (such as, amiloride blockade of ENaC).rises to the level needed to stimulate collecting duct
• Note that since VA is always positive and E
Apical
K is always negative,K secretion so that renal K excretion again matches the apical K current is always directed outward (cell → lumen):
intake. When this new steady state is achieved, extracel-
Basolateral K current:lular [K] remains stable unless dietary intake increases
IBLMK  G
BLM
K * [VB  E
BLM
K ]further, GFR falls, or drugs are given that disrupt the
new balance. Management of hyperkalemia in patients where GBLMK is the sum of all peritubular K conductances.
with renal insufficiency should focus on preventing dis-
• K current across the BLM is directed outward (cell → blood)
ruption of this new steady state by reviewing drug ther- under control conditions because VB is less negative than EBLMK .
apy and dietary counseling. However, high peritubular [K] and/or treatment with mineralo-
corticoids lowers VA (by increasing inward current through ENaC)Our proposal that the elevation in plasma [K] seen
and can cause VB (and therefore VT) to hyperpolarize (both byin many patients with chronic renal insufficiency is an increasing BLM GK and by activating the pump) more negative
adaptive signal for promoting kaliuresis and that hyper- than EBLMK , leading to K entry across the BLM (blood → cell),
promoting more K secretion through apical ROMK channels.kalemia is necessary for homeostasis requires further
basic and clinical investigation. For example, the physio-
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